Rights and permissions
About this article
Cite this article
Bicalutamide the better option in prostate cancer?. Pharmacoecon. Outcomes News 231, 7 (1999). https://doi.org/10.1007/BF03275131
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03275131